alexa Decalcification does not Affect Immunohistochemical Stain of HBME-1 on Papillary Thyroid Carcinom

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Decalcification does not Affect Immunohistochemical Stain of HBME-1 on Papillary Thyroid Carcinom

Thyroid carcinoma is the most common endocrine malignancy and 80% of all thyroid malignancies are papillary thyroid carcinoma . The diagnosis of papillary thyroid carcinoma is based on architectural features combined with nuclear features, including nuclear clearing, overlapping, grooves and pseudoinclusions. It is always challenging in our everyday practice to distinguish folicualr variant papillary thyroid carcinoma (FVPTC), one of the subtypes of PTC, from cellular adenomatous nodules. Nuclear clearing in benign thyroid lesion, such as in Hashimoto’s disease may lead pathologists to misdiagnose papillary thyroid carcinoma. In an unusual condition, it may also be difficult for differentiating papillary hyperplastic nodules from papillary thyroid carcinoma.

 

 

 

Bai S, Chiriboga L, Heller K, Patel KN, LiVolsi VA (2014) Decalcification does not Affect Immunohistochemical Stain of HBME-1 on Papillary Thyroid Carcinoma. J Clin Exp Pathol 4:188.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords